Graham Capital Management’s Veracyte VCYT Stock Holding History

Graham Capital Management’s Portfolio VCYT Stock Details VCYT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-14,180	Closed	-$457K	–	1530
2026 Q1	$457K	Buy	14,180 +863	+6%	+$31.9K	0.01%	658
2025 Q4	$561K	Buy	+13,317	New	+$537K	0.01%	586
2025 Q3	–	Sell	-17,686	Closed	-$478K	–	1669
2025 Q2	$478K	Sell	17,686 -10,677	-38%	-$309K	0.01%	844
2025 Q1	$841K	Buy	28,363 +6,576	+30%	+$251K	0.01%	608
2024 Q4	$863K	Buy	21,787 +4,216	+24%	+$160K	0.01%	539
2024 Q3	$598K	Buy	+17,571	New	+$494K	0.01%	596
2024 Q2	–	Sell	-42,490	Closed	-$942K	–	1388
2024 Q1	$942K	Buy	42,490 +12,360	+41%	+$302K	0.02%	444
2023 Q4	$829K	Buy	30,130 +3,944	+15%	+$95.2K	0.02%	434
2023 Q3	$585K	Buy	+26,186	New	+$673K	0.01%	519
2022 Q4	–	Sell	-25,216	Closed	-$418K	–	1364
2022 Q3	$418K	Buy	+25,216	New	+$567K	0.02%	801

Other funds holding VCYT

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Graham Capital Management's VCYT Position: Q2 2026 in Review

Graham Capital Management sold out of Veracyte (VCYT) in Q2 2026, closing a stake of 14,180 shares — an estimated $457K sold.

Graham Capital Management first reported a position in VCYT in Q3 2022 and held it in 10 quarters. The position peaked at $942K in Q1 2024. 370 funds tracked by Wall St. Rank hold VCYT as of Q2 2026.

Graham Capital Management reported no remaining Veracyte position as of Q2 2026 after selling out during the quarter.
Graham Capital Management sold 14,180 Veracyte shares in Q2 2026, an estimated $457K.
Graham Capital Management first reported a position in Veracyte in Q3 2022 and held it in 10 quarters.
Graham Capital Management's Veracyte position peaked at $942K in Q1 2024.
370 funds tracked by Wall St. Rank held Veracyte as of Q2 2026.

Based on Graham Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.